Sort
141,003 grants matching “cytokine”
Screening Complete TB Proteome for Protective Antigens
$879,258Alan Greener · Gene Therapy Systems, Inc. · R44 · FY2008 · AI
Role Of Monocytes In AIDS And As Targets For Antiviral Therapy
$879,248Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
Outcome Modifying Genes in Sickle Cell Disease
$879,236Duke University · R01 · FY2003 · HL
Systematic Investigation of Protein Ubiquitination in ARDS
$879,209Beibei Chen · University Of Pittsburgh At Pittsburgh · R35 · FY2020 · HL
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$878,832Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2014 · AI
Preventing GVHD by inhibition of alloantigen presentation in the gut
$878,801Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2025 · HL
Biospecimen Core for Procurement of Human Somatic and Reproductive Tissues for Senescent Cell Mapping
$878,705Francesca E. Duncan · Buck Institute For Research On Aging · U54 · FY2021 · AG
Excellence in Research: The role of STAT5 signaling in placental dysfunction, inflammation, and fetal immune activation
$878,496Erica L Johnson · Morehouse School Of Medicine · · FY2025 · BIO
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
$878,495Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$878,466Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · AI
A therapeutic vaccine for chronic hepatitis B
$878,409David R. Milich · Vlp Biotech, Inc. · R44 · FY2019 · AI
Pharmacokinetic and Efficacy Studies of the Aerosolized PAR2 Antagonist, C781, for the Treatment of Asthma
$878,390Kathryn Anne Defea · Parmedics, Inc. · R44 · FY2024 · HL
HIV, Inflammation, and Endothelial Dysfunction
$878,381Samir Kumar Gupta · Indiana University Indianapolis · R01 · FY2010 · HL
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$878,370Matthew S Freiberg · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL
The Danger Model 2: how tissues control Immunity
$878,217Polly C Matzinger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Dust Mite, Cockroach and Cat Allergens in Asthma
$878,086Thomas A. Platts-Mills · University Of Virginia · R01 · FY2016 · AI
A multivalent, easy-to-use product to mitigate and treat radiation exposure
$877,876Richard Yen · Fibroplate, Inc. · R44 · FY2021 · AI
Developing new immunotherapies based of CD4 T cells
$877,856Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
A chemical chaperomics platform for AD
$877,816Gabriela Chiosis · Sloan-Kettering Inst Can Research · R56 · FY2019 · AG
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
$877,772Yung-Chi Cheng · Yale University · P01 · FY2016 · CA
Immune based interventions for HIV eradication
$877,752Mirko Paiardini · Emory University · R01 · FY2016 · AI
Characterization of Signaling Pathways involved in Cell Death and Survival
$877,448Srinivasa M. Srinivasula · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
CELLULAR BASIS OF HYPERSENSITIVITY DISEASES IN HUMANS
$877,439Brigham And Women'S Hospital · P01 · FY2002 · AI
GrowthDifferentiation Factors in Organogenesis
$877,374Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Methamphetamine, Stress and SIV: Effects at Blood-Brain Barrier and Lymph Nodes
$877,318John P Capitanio · University Of California At Davis · R01 · FY2010 · DA